Evidence map›Paper›PMID 27045955›Full record

ArticlePloS one2016

Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma.

Cassandra L Miller, Sureshkumar Muthupalani, Zeli Shen, Frauke Drees, Zhongming Ge, Yan Feng, Xiaowei Chen, Guanyu Gong, Karan K Nagar, Timothy C Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. International journal of systematic and evolutionary microbiology · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Cassandra L MillerDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Sureshkumar MuthupalaniDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Zeli ShenDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Frauke DreesDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Zhongming GeDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Yan FengDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Xiaowei ChenDivision of Digestive and Liver Diseases, Columbia University, New York, NY, United States of America.
Guanyu GongDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Karan K NagarDivision of Digestive and Liver Diseases, Columbia University, New York, NY, United States of America.
Timothy C WangDivision of Digestive and Liver Diseases, Columbia University, New York, NY, United States of America.
Frank B GertlerDavid H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
James G FoxDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States of America.
Massachusetts Institute of Technology · USColumbia University · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Paula T Hammond · 1985 to 2026
$93.9M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
Biomedical Research Training for Veterinary ScientistsT32OD010978 · OD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 2012 to 2017
$2.2M
Biophysical Regulation of Breast DifferentiationR01CA114462 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KEELY, PATRICIA J · 2010 to 2014
$1.5M
Diagnosis and Pathobiology of Emerging Enterohepatic Helicobacter spp. in MiceR01OD011141 · OD · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 2012 to 2014
$1.2M
NCI NIH HHS P30 CA014051NCI NIH HHS P30-CA14051NCI NIH HHS R01 CA114462NCI NIH HHS U54-CA114462NIEHS NIH HHS P30 ES002109NIEHS NIH HHS P30-ES002109NIH HHS R01 OD011141NIH HHS R01-OD011141NIH HHS T32 OD010978NIH HHS T32-OD010978
6 · The paper itself

Abstract

During a survey of clinical rectal prolapse (RP) cases in the mouse population at MIT animal research facilities, a high incidence of RP in the lamellipodin knock-out strain, C57BL/6-Raph1tm1Fbg (Lpd-/-) was documented. Upon further investigation, the Lpd-/- colony was found to be infected with multiple endemic enterohepatic Helicobacter species (EHS). Lpd-/- mice, a transgenic mouse strain produced at MIT, have not previously shown a distinct immune phenotype and are not highly susceptible to other opportunistic infections. Predominantly male Lpd-/- mice with RP exhibited lesions consistent with invasive rectal carcinoma concomitant to clinically evident RP. Multiple inflammatory cytokines, CD11b+Gr1+ myeloid-derived suppressor cell (MDSC) populations, and epithelial cells positive for a DNA damage biomarker, H2AX, were elevated in affected tissue, supporting their role in the neoplastic process. An evaluation of Lpd-/- mice with RP compared to EHS-infected, but clinically normal (CN) Lpd-/- animals indicated that all of these mice exhibit some degree of lower bowel inflammation; however, mice with prolapses had significantly higher degree of focal lesions at the colo-rectal junction. When Helicobacter spp. infections were eliminated in Lpd-/- mice by embryo transfer rederivation, the disease phenotype was abrogated, implicating EHS as a contributing factor in the development of rectal carcinoma. Here we describe lesions in Lpd-/- male mice consistent with a focal inflammation-induced neoplastic transformation and propose this strain as a mouse model of rectal carcinoma.

Indexed as

Disease Models, AnimalAnimalsCarrier ProteinsDNA DamageHumansIn Situ Hybridization, FluorescenceMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutRectal NeoplasmsCarrier ProteinsMembrane ProteinsRAPH1 protein, human

Identifiers

PMID27045955
PMCPMC4821566
OpenAlexW2332417153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.